ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
Open Access
- 2 March 2017
- journal article
- conference paper
- Published by S. Karger AG in Neuroendocrinology
- Vol. 105 (3), 245-254
- https://doi.org/10.1159/000461583
Abstract
Neuroendocrine tumors of the small intestine are the most common causes of the carcinoid syndrome. Carcinoid heart disease occurs in more than half of the patients with the carcinoid syndrome. Patients with carcinoid heart disease who need to undergo surgery should also undergo preoperative evaluation by an expert cardiologist. Treatment with long-acting somatostatin analogs aims at controlling the excessive hormonal output and symptoms related to the carcinoid syndrome and at preventing a carcinoid crisis during interventions. Patients with a gastrinoma require pre- and postoperative treatment with high doses of proton pump inhibitors. Patients with a glucagonoma require somatostatin analog treatment and nutritional supplementation. Patients with a VIPoma also require somatostatin analog treatment and intravenous fluid and electrolyte therapy. Insulinoma patients generally require intravenous glucose infusion prior to operation. In patients with localized operable insulinoma, somatostatin analog infusion should only be considered after the effect of this therapy has been electively studied.Keywords
This publication has 57 references indexed in Scilit:
- Carcinoid syndrome and perioperative anesthetic considerationsJournal of Clinical Anesthesia, 2011
- Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine TumorJournal of Clinical Oncology, 2009
- Analysis of 150 Patients With Carcinoid Syndrome Seen in a Single Year at One Institution in the First Decade of the Twenty-First CenturyThe American Journal of Cardiology, 2008
- Gastroenteropancreatic neuroendocrine tumoursThe Lancet Oncology, 2008
- Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotateEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Carcinoid syndrome and carcinoid crisis secondary to a metastatic carcinoid tumour of the lung: a therapeutic challengeEuropean Journal of Gastroenterology & Hepatology, 2007
- InsulinomaBest Practice & Research Clinical Gastroenterology, 2005
- Rare endocrine tumours of the GI tractBest Practice & Research Clinical Gastroenterology, 2005
- Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger–Ellison syndromeGastroenterology, 2000
- Severe hypertension and flushing in a patient with a non‐metastatic carcinoid tumourAnaesthesia, 1982